AAAAAA
Results: 76-100/191
Citation: ABSTRACTS (POSTER PRESENTATIONS) FROM THE 15TH INTERNATIONAL-CONFERENCE ON HUMAN TUMOR-MARKERS, Journal of tumor marker oncology, 13(2), 1998, pp. 50-67
Authors:
KREUTZ FT
SURESH MR
Citation: Ft. Kreutz et Mr. Suresh, DEVELOPMENT OF A NEW 2ND-GENERATION HETEROLOGOUS DOUBLE-DETERMINANT BISPECIFIC ANTIBODY-BASED CA125 IMMUNOASSAY, Journal of tumor marker oncology, 13(2), 1998, pp. 69-77
Authors:
BYRIALSEN A
VONEYBEN FE
KRISTIANSEN K
Citation: A. Byrialsen et al., CARCINOMA IN-SITU OF THE TESTIS AND SEMINOMA EXPRESS A HIGH-LEVEL OF LACTATE-DEHYDROGENASE (LD) SUBUNIT-B BUT NO LD SUBUNIT-C, Journal of tumor marker oncology, 13(2), 1998, pp. 79-86
Authors:
NISMAN B
LAFAIR J
LYASS O
DRANITZKIELHALEL M
BARAK V
Citation: B. Nisman et al., SERUM LEVELS OF CEA, SCC, TPS AND CYFRA-21-1 IN HEMODIALYSIS-PATIENTS, Journal of tumor marker oncology, 13(2), 1998, pp. 87-93
Authors:
WANG LQ
YU YZ
SELL S
Citation: Lq. Wang et al., P53 AND PCNA AS DIFFERENTIATION MARKERS OF HEPATOCELLULAR CARCINOMAS, Journal of tumor marker oncology, 13(1), 1998, pp. 5-13
Authors:
SHALITIN C
VALANSI C
ADMON A
MOSKOVITZ B
SEGAL R
EPELBAUM R
NATIV O
Citation: C. Shalitin et al., ELEVATED LEVELS OF HAPTOGLOBIN-RELATED PROTEIN IN SERA OF CANCER-PATIENTS, Journal of tumor marker oncology, 13(1), 1998, pp. 15-25
Authors:
RON IG
DALE A
TIROSH R
DEUTSCH M
Citation: Ig. Ron et al., THE POTENTIAL OF NEW SCREENING-TESTS FOR COLORECTAL-CANCER TO ENHANCEPATIENT ACCEPTABILITY, Journal of tumor marker oncology, 13(1), 1998, pp. 27-32
Authors:
NISMAN B
LAFAIR J
LYASS O
DRANITZKIELHALEL M
BARAK V
Citation: B. Nisman et al., SERUM LEVELS OF CEA, SCC, TPS AND CYFRA-21-1 IN HEMODIALYSIS-PATIENTS, Journal of tumor marker oncology, 13(1), 1998, pp. 33-39
Authors:
MERMERSHTAIN W
SEBBAG G
ARIAD S
COHEN Y
Citation: W. Mermershtain et al., EXTREMELY ELEVATED CA-19-9 SERUM LEVEL IN A PATIENT WITH ACUTE BILIARY OBSTRUCTION AND CHRONIC CHOLECYSTITIS, Journal of tumor marker oncology, 13(1), 1998, pp. 41-42
Authors:
KHINE M
KLAVINS JV
Citation: M. Khine et Jv. Klavins, USING AFP TO DETECT FETAL ABNORMALITIES, Journal of tumor marker oncology, 13(1), 1998, pp. 43-51
Citation: ANDERS,FRITZ, THE AWARDEE OF THE 1997-PRINCE-HITACHI-PRIZE-FOR-COMPARATIVE-ONCOLOGY, Journal of tumor marker oncology, 12(4), 1997, pp. 5-7
Authors:
BIAVA PM
CARLUCCIO A
Citation: Pm. Biava et A. Carluccio, ACTIVATION OF ANTIONCOGENE P53 PRODUCED BY EMBRYONIC EXTRACTS IN IN-VITRO TUMOR-CELLS, Journal of tumor marker oncology, 12(4), 1997, pp. 9-15
Authors:
BARAK V
NISMAN B
ROISMAN I
HUBERT A
FARBSTEIN H
BAIDER L
KAPLAN A
HALPERIN T
STEPHANOS S
PERETZ T
Citation: V. Barak et al., TPS IN ASSESSING RESPONSE TO THERAPY AND PROGNOSIS OF BREAST-CANCER PATIENTS TREATED WITH INTERFERONS, Journal of tumor marker oncology, 12(4), 1997, pp. 17-25
Authors:
IOACHIM E
CHARCHANDI A
STAVROPOULOS NE
ATHANASSIOU E
AGNANTIS NJ
Citation: E. Ioachim et al., EXPRESSION OF THE CELL-ADHESION MOLECULE CD44 IN TRANSITIONAL-CELL CARCINOMA OF THE URINARY-BLADDER, Journal of tumor marker oncology, 12(4), 1997, pp. 27-36
Authors:
VACATA V
OEHR P
RINK H
RUHLMANN J
Citation: V. Vacata et al., COMPUTER MODELING OF TUMOR-GROWTH AND TREATMENT, Journal of tumor marker oncology, 12(4), 1997, pp. 37-40
Authors:
OEHR P
RINK H
VACATA V
RUHLMANN J
Citation: P. Oehr et al., TPS IN HELA-TISSUE CULTURE IS NOT A PROLIFERATION MARKER, Journal of tumor marker oncology, 12(4), 1997, pp. 41-45
Authors:
PUGATSCH T
OR R
SLAVIN S
KAPELUSHNIK J
Citation: T. Pugatsch et al., AMELOGENIN AS MARKER FOR BONE-MARROW ENGRAFTMENT - A SHORT-TERM STUDY, Journal of tumor marker oncology, 12(4), 1997, pp. 47-51
Citation: SUPPLEMENTARY ABSTRACTS AND POSTERS FROM THE IATMO CONFERENCE IN JERUSALEM 1997, Journal of tumor marker oncology, 12(4), 1997, pp. 53-58
Authors:
FAHIM FA
ESMAT AY
MADY EA
AMIN MA
Citation: Fa. Fahim et al., PHARMACOKINETIC AND TUMOR STUDIES OF ALOIN (A NATURAL ANTHRAQUINONE) ON MICE BEARING SOLID EHRLICH CARCINOMA (VOL 12, PG 129, 1997), Journal of tumor marker oncology, 12(4), 1997, pp. 63-64
Authors:
BUSCH H
Citation: H. Busch, NUCLEOLAR AND NUCLEOLONEMAL PROTEINS OF CANCER-CELLS, Journal of tumor marker oncology, 12(3), 1997, pp. 5-68
Citation: 14TH INTERNATIONAL-CONFERENCE ON HUMAN TUMOR-MARKERS - JUNE 15-19, 1997 - JERUSALEM - ABSTRACTS, Journal of tumor marker oncology, 12(2), 1997, pp. 26
Authors:
YUAN YW
ZHANG JR
LU CD
QI GR
Citation: Yw. Yuan et al., IN-VITRO CLEAVAGE OF MDR1 MESSENGER-RNA FRAGMENT BY SYNTHETIC RIBOZYME (RZ) AND TRANSCRIBED RIBOZYME FROM TNA-TRIMMING PLASMID, Journal of tumor marker oncology, 12(2), 1997, pp. 121-125
Authors:
FAHIM FA
ESMAT AY
MADY EA
AMIN MA
Citation: Fa. Fahim et al., PHARMACOKINETIC AND TUMOR STUDIES OF ALOIN (A NATURAL ANTHRAQUINONE) ON MICE BEARING SOLID EHRLICH CARCINOMA, Journal of tumor marker oncology, 12(2), 1997, pp. 127-134
Authors:
YASASEVER V
DINCER M
CAMLYCA H
KARALOOLU D
KIZIR A
TOPUZ E
DALAY N
Citation: V. Yasasever et al., CYFRA-21-1 IS THE MOST SENSITIVE TUMOR-MARKER IN NONSMALL CELL LUNG-CANCER, Journal of tumor marker oncology, 12(2), 1997, pp. 135-140
Authors:
ELHOUSEINI ME
ABUELZAHAUB HSH
MOHARRAM NZ
AMR MN
ELMENIAWY FA
Citation: Me. Elhouseini et al., EVALUATION OF SERUM LEVEL OF SOME BIOLOGICAL MARKERS IN NORMAL BILHARZIAL INFECTED AND PATIENTS WITH DIFFERENT TYPES OF CANCER, Journal of tumor marker oncology, 12(2), 1997, pp. 141-148